loader image
Close
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us
Menu
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us
Facebook
  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Old Issuances
  • Services
    • eServices
    • ePortal
    • ePortal2
    • Doctrack
    • RRDportal
Menu
  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Old Issuances
  • Services
    • eServices
    • ePortal
    • ePortal2
    • Doctrack
    • RRDportal

Category: Drugs Advisories

FDA Advisory No.2022-1081-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na beripikadong pekeng gamot: 1. Phenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Bioflu®) […]

FDA Advisory No.2022-1080-A || Babala sa Publiko tungkol sa Pagbili at Paggamit ng Beripikadong Pekeng Gamot na “Mefenamic Acid (Ponstan®) 500 mg Tablet”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng sumusunod na beripikadong pekeng gamot: 1. Mefenamic Acid (Ponstan®) 500 mg Tablet Ang lahat ng […]

FDA Advisory No.2022-1080 || Public Health Warning Against the Purchase and Use of the Verified Counterfeit Drug Product “Mefenamic Acid (Ponstan®) 500 mg Tablet”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following product: 1. Mefenamic Acid (Ponstan®) 500 mg Tablet All […]

FDA Advisory No.2022-1081 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following products: 1. Phenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol […]

FDA Advisory No.2022-1066-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na “Loperamide (Imodium®) 2 mg Capsule 200’s”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng beripikadong pekeng gamot: 1. Loperamide (Imodium®) 2 mg Capsule 200’s Ang lahat ng healthcare professionals […]

FDA Advisory No.2022-1066 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Loperamide (Imodium®) 2 mg Capsule 200’s”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following product: All healthcare professionals and the general public are […]

FDA Advisory No.2022-0979 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic PERFECT SKIN ALL NATURALS REJUVENATING SET:

The Food and Drug Administration (FDA) warns the public from purchasing and using the unauthorized cosmetic product, PERFECT SKIN ALL NATURALS REJUVENATING SET 1. PERFECT SKIN ALL NATURALS SUNBLOCK GEL […]

FDA Advisory No.2022-1036 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Ibuprofen/ Paracetamol (Alaxan® FR) 200 mg / 325 mg Capsule”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the following product: Ibuprofen/ Paracetamol (Alaxan® FR) 200 mg / 325 […]

FDA Advisory No.2022-1035-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Molnupiravir 200 mg Capsules Moluxin 200 40’s”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: 1. Molnupiravir 200 mg Capsules Moluxin 200 40’s Napatunayan sa pamamagitan […]

FDA Advisory No.2022-1035 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Molnupiravir 200 mg Capsules Moluxin 200 40’s”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: FDA Post-Marketing Surveillance (PMS) activities have verified that the abovementioned drug […]

← older
Quick Menus

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts
  • FDA Advisory No.2022-1081-A || Babala sa Publiko tungkol sa Paggamit…

  • FDA Advisory No.2022-1078 || Public Health Warning Against the Purchase…

  • FDA Advisory No.2022-1077 || Public Health Warning Against the Purchase…

  • FDA Advisory No.2022-1076 || Public Health Warning Against the Purchase…

Quick Links
  • Department of Health (DOH)
  • U.S Food and Drug Administration (U.S FDA)
  • Department of Information and Communications Technology (DICT)
  • Department of Science and Technology (DOST)
  • Anti-Red Tape Authority (ARTA)
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City
Tel. no: (02) 8857-1900 local 1000
[email protected]
 
 
 
Landline: 

(02) 8857-1900
l
ocal 1000
(02) 8842-5635

Mobile:

09617709691
09616845994
09610574926

Email: [email protected]

Copyright © 2022. All Rights Reserved.

Shares